Vertex Pharma (VRTX) Updates on Pipeline; Offers FY15 Financial Goals

Go back to Vertex Pharma (VRTX) Updates on Pipeline; Offers FY15 Financial Goals

Janney Capital Starts Vertex (VRTX) at Neutral

January 9, 2015 7:25 AM EST

Janney Capital initiated coverage on Vertex (NASDAQ: VRTX) with a Neutral rating and a price target of $126.00.

For an analyst ratings summary and ratings history on Vertex click here. For more ratings news on Vertex click here.

Shares of Vertex closed at $123.97 yesterday.

... More